GlassScriptPhysician profile
Arif H Kamal
NPI 1417063694
$49,885.75
in general payments reported to CMS, 2019-2025
6 companies · $357 in 2025
The $357 reported for 2025 was less than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,817 · 2020: $11K · 2021: $14K · 2022: $15K · 2024: $2,847 · 2025: $357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,530 · Food and Beverage: $674.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,530.00 |
| Food and Beverage | $673.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $22,137.50 | 2020-2022 | |
| Gilead Sciences, INC. | $14,442.56 | 2022-2024 | Trodelvy |
| Astrazeneca Pharmaceuticals LP | $10,999.19 | 2019-2022 | |
| Glaxosmithkline, LLC. | $1,950.00 | 2021 | |
| Pfizer INC. | $206.50 | 2025 | |
| Genentech USA, INC. | $150.00 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arif Kamal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.